Dates of Preliminary Announcement of Results and of the Annual General Meeting

25 February 2008

LiDCO Group Plc, the cardiovascular monitoring company, notifies the market that it will release preliminary results of the Company for the year ended 31 January 2008 on 24 April 2008. The Annual General Meeting will be held on 25 June 2008.

There will be an analyst briefing at 10am on 24 April 2008 at the offices of Buchanan Communications, 45 Moorfields, London EC2. If you are interested in attending the briefing, please contact Buchanan on 0207 466 5000.

 

For more information please contact:  
   
LiDCO Group Plc   Tel: +44 (0)20 7749 1500
Terry O’Brien - Chief Executive
John Rowland - Company Secretary		  
     
Buchanan Communications   Tel: +44 (0)20 7466 5000
Tim Anderson, James Strong  

 

Notes for Editors

About LiDCO Group Plc

LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

  • LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume (PPV and SVV).
  • LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.
  • LiDCOview - software product for use on a PC: designed to aid clinical audit, teaching and research activities.
  • LiDCOlive - software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.

Distribution Network:

The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of speciality critical care and anesthesia distributors.

 

Back to News Releases